Trial Profile
A Study to Evaluate the Efficacy, Pharmacokinetics and Safety of Fevipiprant in Atopic Patients With Mild-To-Moderate Persistent Asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jan 2016
Price :
$35
*
At a glance
- Drugs Fevipiprant (Primary)
- Indications Asthma
- Focus Adverse reactions; Pharmacokinetics; Proof of concept; Therapeutic Use
- 12 Jan 2016 New trial record